Tylenol should probably not be available over the counter. It has a narrow therapeutic index and safer, equally effective alternatives.
As it is, we have a two tier system. Consumers are trained that OTC drugs are so safe they barely have to glance at the instructions. APAP is vastly more dangerous than its peers on the OTC shelf, and consumers are placed at risk.